Crispr Therapeutics shares owned by Wincap Financial
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Wincap Financial
from 13F filings
Historical chart of Wincap Financial investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Wincap Financial consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Wincap Financial
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $610k | 9.4k | 64.81 |
| 2025-06-30 | $452k | 9.3k | 48.64 |
| 2025-03-31 | $315k | 9.3k | 34.03 |
| 2024-12-31 | $286k | 7.3k | 39.36 |